Cargando…

Immune response to second dose of MMR vaccine in Indian children

BACKGROUND & OBJECTIVES: MMR vaccine in a two dose schedule has successfully eliminated measles, mumps and rubella from many developed countries. In India, it is not a part of national immunization programme but is included in the State immunization programme of Delhi as a single dose between 15...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomber, Sunil, Arora, Shilpa Khanna, Das, Shukla, Ramachandran, V. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193710/ https://www.ncbi.nlm.nih.gov/pubmed/21985812

Ejemplares similares

Measles, Mumps, and Rubella Antibody: Patterns of Persistence and Rate of Decline Following the Second Dose of the MMR Vaccine
por: Seagle, Emma, et al.
Publicado: (2017)

Delayed adaptive immunity is related to higher MMR vaccine-induced antibody titers in children
por: Strömbeck, Anna, et al.
Publicado: (2016)

Are pediatricians responsible for maintaining high MMR vaccination coverage? Nationwide survey on parental knowledge and attitudes towards MMR vaccine in Serbia
por: Loncarevic, Goranka S., et al.
Publicado: (2023)

Asthma and the immune response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study
por: Patel, Apurvi R, et al.
Publicado: (2013)

Improving health literacy with mumps, measles and rubella (MMR) vaccination: comparison of the readability of MMR patient-facing literature and MMR scientific abstracts
por: Downey, Tina, et al.
Publicado: (2022)

Profiling of Measles-Specific Humoral Immunity in Individuals Following Two Doses of MMR Vaccine Using Proteome Microarrays
por: Haralambieva, Iana H., et al.
Publicado: (2015)

Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology
por: Haralambieva, Iana H., et al.
Publicado: (2017)

Inequity in Timeliness of MMR Vaccination in Children Living in the Suburbs of Iranian Cities
por: Jadidi, Rahmatollah, et al.
Publicado: (2015)

Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program
por: dos Santos, Eliane Matos, et al.
Publicado: (2014)

Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients
por: Casale, Maddalena, et al.
Publicado: (2021)

Evidence and policymaking: The introduction of MMR vaccine in the Netherlands
por: Blume, Stuart, et al.
Publicado: (2010)

A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration
Publicado: (2019)

Immune desert in MMR-deficient tumors predicts poor responsiveness of immune checkpoint inhibition
por: Zheng, Guoxing, et al.
Publicado: (2023)

Serological Response to COVID-19 and Its Association With Measles-Rubella (MR)-Containing Vaccines
por: Shrivastava, Jahnavi, et al.
Publicado: (2023)

Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens
por: Mysore, Vijayashree, et al.
Publicado: (2021)

Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants
por: Hu, Siyuan, et al.
Publicado: (2022)

The MMR vaccine and autism: Sensation, refutation, retraction, and fraud
por: Rao, T. S. Sathyanarayana, et al.
Publicado: (2011)

Acute hemorrhagic edema of infancy after MMR vaccine
por: Binamer, Yousef
Publicado: (2015)

MMR vaccination in England falls below critical threshold
por: Kirby, Tony
Publicado: (2022)

1723. Mumps Attack Rates Following Administration of a Third Dose of MMR Vaccine to School-Aged Children, Arkansas, 2016–2017
por: Guo, Angela, et al.
Publicado: (2018)

Nurses’ Perceptions Of MMR Vaccine Hesitancy In An Area With Low Vaccination Coverage
por: Jama, Asha, et al.
Publicado: (2019)

Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens
por: Mysore, Vijayashree, et al.
Publicado: (2021)

Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer
por: Inamori, Koji, et al.
Publicado: (2021)

Measles, misinformation, and risk: personal belief exemptions and the MMR vaccine
por: Bowes, Johnathan
Publicado: (2016)

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
por: Quach, Huy Quang, et al.
Publicado: (2022)

Revisiting the potential role of BCG and MMR vaccines in COVID-19
por: Bayram, Zeina, et al.
Publicado: (2022)

Do children who receive an ‘early dose’ of MMR vaccine during a measles outbreak return for their regularly scheduled dose? A retrospective population-based study
por: Guo, Xiaoyan, et al.
Publicado: (2016)

NEW EVIDENCE PUBLISHED IN THE COCHRANE LIBRARY TODAY FINDS MMR, MMRV AND MMR+V VACCINES ARE EFFECTIVE AND THAT THEY ARE NOT ASSOCIATED WITH INCREASED RISK OF AUTISM
Publicado: (2020)

Severe Immune Thrombocytopenia Following MMR Vaccination with Rapid Recovery: A Case Report and Review of Literature
por: Akbik, Majd, et al.
Publicado: (2020)

Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors
por: Salewski, Inken, et al.
Publicado: (2021)

Application of a fast and cost-effective ‘three-in-one’ MMR ELISA as a tool for surveying anti-MMR humoral immunity: the Hungarian experience
por: Böröcz, K., et al.
Publicado: (2020)

MR/MMR Vaccine in Measles Control: A Case of Missed Opportunity?
por: Sharma, Karun D, et al.
Publicado: (2014)

Common variants associated with general and MMR vaccine-related febrile seizures
por: Feenstra, Bjarke, et al.
Publicado: (2014)

Low vaccine efficacy of mumps component among MMR vaccine recipients in Chennai, India
por: Malaiyan, Jeevan, et al.
Publicado: (2014)

Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme
por: Patić, Aleksandra, et al.
Publicado: (2020)

Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina
por: Vizzotti, Carla, et al.
Publicado: (2023)

Dengue encephalitis in children
por: Arora, Shilpa Khanna, et al.
Publicado: (2012)

Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12–15 Months
por: Mufson, Maurice A., et al.
Publicado: (2015)

Differential Demographic and Clinical Characteristics between MMR Vaccinated and Unvaccinated Children in South Korea: A Nationwide Study
por: Yoon, Dongwon, et al.
Publicado: (2021)

ACUTE COPD EXACERBATION AFTER THE SECOND DOSE OF COVID-19 VACCINE
por: DURDEVIC, MOMCILO, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_249sed4ju3srs08in1ji12ll5b